Log in

Relevant bibliographies by topics / Chronic ischemic heart disease

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Chronic ischemic heart disease'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chronic ischemic heart disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chronic ischemic heart disease"

1

Tsiatis, Anastasios A., and Michael A. Gent. "Chronic ischemic heart disease." American Heart Journal 139, no. 4 (2000): 0182–88. http://dx.doi.org/10.1067/mhj.2000.104845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gent, Michael, and Robert M. Califf. "Chronic ischemic heart disease." American Heart Journal 139, no. 4 (2000): S182—S188. http://dx.doi.org/10.1016/s0002-8703(00)90069-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Keenan, Andrew M. "Atlas of Heart Diseases: Chronic Ischemic Heart Disease." CLINICAL NUCLEAR MEDICINE 22, no. 9 (1997): 662. http://dx.doi.org/10.1097/00003072-199709000-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dzhaiani, N. A. "CANDESARTAN IN CARDIOLOGY PRACTICE." Medical Council, no. 7 (December 30, 2017): 12–16. http://dx.doi.org/10.21518/2079-701x-2017-7-12-16.

Full text

Abstract:

The most significant risk factor for the development of cardiovascular diseases such as myocardial infarction, ischemic heart disease, chronic heart failure, is arterial hypertension (AH). [1] AH also contributes to the development of cerebrovascular pathology (ischemic or hemorrhagic stroke, transient ischemic attack) and kidney diseases (chronic kidney disease).

APA, Harvard, Vancouver, ISO, and other styles

5

Karpov, Yu A. "Chronic ischemic heart disease: treatment news." Consilium Medicum 18, no. 1 (2016): 38–44. http://dx.doi.org/10.26442/2075-1753_2016.1.38-44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Parfrey, Patrick S., and Robert N. Foley. "Ischemic Heart Disease in Chronic Uremia." Blood Purification 14, no. 4 (1996): 321–26. http://dx.doi.org/10.1159/000170280.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dr., Aijaz Ahmed Dr. Muhammad Nadeem Ahsan Dr. Pooran Mal* Dr. Hamid Nawaz Ali Memon Dr. Samreen and Dr. Sajjad Ali. "ISCHEMIC HEART DISEASE IN PATIENTS OF CHRONIC KIDNEY DISEASE ON MAINTENANCE HEMODIALYSIS." Indo American Journal of Pharmaceutical Sciences 04, no. 11 (2017): 4381–85. https://doi.org/10.5281/zenodo.1064349.

Full text

Abstract:

Objective: To determine the frequency of ischemic heart disease in patients of chronic kidney disease on maintenance hemodialysis Patients and Methods: A total of 160 patients with diagnosis of CKD in department of Nephrology, Liaquat National Hospital Karachi were recruited in this six months cross sectional study. Demographic information was recorded. Then patients were underwent ECG. Reports were assessed and ischemic heart disease was labeled while all the data was collected using the proforma. Results: The mean age of the patients was 55.97±7.27 years. There were 102(63.75%) male a

APA, Harvard, Vancouver, ISO, and other styles

8

Stride, Nis, Steen Larsen, Martin Hey-Mogensen, et al. "Impaired mitochondrial function in chronically ischemic human heart." American Journal of Physiology-Heart and Circulatory Physiology 304, no. 11 (2013): H1407—H1414. http://dx.doi.org/10.1152/ajpheart.00991.2012.

Full text

Abstract:

Chronic ischemic heart disease is associated with myocardial hypoperfusion. The resulting hypoxia potentially inflicts damage upon the mitochondria, leading to a compromised energetic state. Furthermore, ischemic damage may cause excessive production of reactive oxygen species (ROS), producing mitochondrial damage, hereby reinforcing a vicious circle. Ischemic preconditioning has been proven protective in acute ischemia, but the subject of chronic ischemic preconditioning has not been explored in humans. We hypothesized that mitochondrial respiratory capacity would be diminished in chronic isc

APA, Harvard, Vancouver, ISO, and other styles

9

Parfrey, Patrick S., John D. Harnett, and Robert N. Foley. "Heart failure and ischemic heart disease in chronic uremia." Current Opinion in Nephrology and Hypertension 4, no. 2 (1995): 105–10. http://dx.doi.org/10.1097/00041552-199503000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bales, Amy C. "Medical management of chronic ischemic heart disease." Postgraduate Medicine 115, no. 2 (2004): 39–46. http://dx.doi.org/10.3810/pgm.2004.02.1439.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Chronic ischemic heart disease"

1

Shuper, V. A. "Clinical features of chronic obstructive pulmonary disease combined with ischemic heart disease." Thesis, БДМУ, 2017. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/17112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Michallek, Florian [Verfasser]. "Fractal analysis of the ischemic transition region in chronic ischemic heart disease using Magnetic Resonance Imaging / Florian Michallek." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2017. http://d-nb.info/1127045822/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Shuper, V. O. "Investigation of the respiratory function characteristics of patients with chronic obstructive pulmonary disease combined with ischemic heart disease." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18602.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bobkovych, K. O. "Correction of vegetative imbalance in patients with ischemic heart disease and concomitant chronic non-calculous cholecystitis." Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nilsson, Ulf. "Cardiovascular aspects on chronic obstructive pulmonary disease : with focus on ischemic ECG abnormalities, QT prolongation and arterial stiffness." Doctoral thesis, Umeå universitet, Medicin, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-138787.

Full text

Abstract:

Background Chronic Obstructive Pulmonary disease (COPD) is an under-diagnosed disease with a prevalence of approximately 10%, highly dependent on age and smoking habits. Comorbidities are common in COPD and of these, cardiovascular diseases (CVD) are the most common. COPD is the fourth leading cause of death globally, and CVD probably contribute to the high mortality. Within CVD, Ischemic Heart Disease (IHD) is the most common. It is highly clinically relevant to identify signs of ischemic heart disease, other cardiac conditions, and risk factors for CVD in COPD. Electrocardiogram (ECG) is a s

APA, Harvard, Vancouver, ISO, and other styles

6

Nemish, I. L. "The diagnostic value of the COPD assessment test and exacerbations frequency in patients with chronic obstructive pulmonary disease, ischemic heart disease and obesity." Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nicholas, Makayla J. "Cardiovascular Impacts of Stress and a Western Diet: Synergistic Effects of Lifestyle Risk Factors on Infarct Tolerance and Cardioprotection." Thesis, Griffith University, 2022. http://hdl.handle.net/10072/415306.

Full text

Abstract:

Introduction: Ischemic heart disease (IHD) is one of the leading causes of death from a non-communicable disease globally. Multimorbidity - the co-occurrence of two or more chronic conditions - is becoming highly prevalent in patients suffering IHD. Recently, mood and metabolic disorders have been found to share mechanistic pathways in disease progression, with mood disorders such as major depressive disorder (MDD) and chronic stress (CS), and metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome (MetS) contributing to cardiovascular disease (CVD) risk an

APA, Harvard, Vancouver, ISO, and other styles

8

Fossati, S. "Acute cardiovascular effects of exposure to airborne particulate matter : a study of possible pathogenetic mechanisms." Doctoral thesis, Università degli Studi di Milano, 2009. http://hdl.handle.net/2434/64549.

Full text

Abstract:

Introduction Increased levels of particulate matter air pollution (PM) have been associated with increased cardiovascular morbidity and mortality, especially in elderly adults and in people suffering from cardiovascular or lung diseases. The mechanisms behind these effects are still unknown, although some hypothesis have been postulated that include a modification of autonomic regulation of heart rhythm and the induction of arrhythmic events. Which fraction of PM is the most harmful is still controversial, and few studies investigated the role of personal exposure to different fractions, and

APA, Harvard, Vancouver, ISO, and other styles

9

Lymbury, Robyn S. "Cardiovascular Disease, Antioxidant Enzyme Systems, and Selenium." Thesis, Griffith University, 2008. http://hdl.handle.net/10072/367925.

Full text

Abstract:

Globally, cardiovascular disease (CVD) is the leading cause of mortality, representing 30 % of all deaths in 2005. The prevalence of CVD is predicted to increase steadily over the coming years and this has been attributed to a number of factors including an increase in overall life expectancy, as well as a projected increase in the number of people with common risk factors. As in most developed countries, Australia is experiencing a rise in the proportion of aged population, with current predictions estimating that by 2051, the number of people aged 65 years and over will increase from the cur

APA, Harvard, Vancouver, ISO, and other styles

10

Li, Zipeng. "Sustained-release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model." Kyoto University, 2018. http://hdl.handle.net/2433/235987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Chronic ischemic heart disease"

1

George, Beller, ed. Chronic ischemic heart disease. Mosby, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Concistrè, Giovanni, ed. Ischemic Heart Disease. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-25879-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

K, Shah Prediman, and De Feyter Pim J, eds. Ischemic heart disease. Manson, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Renu, Virmani, and Forman Mervyn B, eds. Nonatherosclerotic ischemic heart disease. Raven Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mueller, Xavier M. Lasers for Ischemic Heart Disease. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56798-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Roncella, Adriana, and Christian Pristipino, eds. Psychotherapy for Ischemic Heart Disease. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-33214-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

T, Basson Craig, and Lerman Bruce B, eds. Ischemic heart disease and arrhythmias. Demos Medical Pub., 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Brian, Buxton, Frazier O. Howard, and Westaby Stephen, eds. Ischemic heart disease: Surgical management. Mosby, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Seibu, Mochizuki, ed. The ischemic heart. Kluwer Academic Publishers, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Wiviott, Stephen D., ed. Antiplatelet Therapy In Ischemic Heart Disease. Wiley-Blackwell, 2008. http://dx.doi.org/10.1002/9781444303339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Chronic ischemic heart disease"

1

Choo, Ki Seok, and Yeon Hyeon Choe. "Chronic Ischemic Heart Disease." In Practical Textbook of Cardiac CT and MRI. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-36397-9_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Stys, Tomasz, Susan Simandl, and Peter F. Cohn. "Chronic Ischemic Heart Disease." In Cardiology for the primary care Physician. Current Medicine Group, 2001. http://dx.doi.org/10.1007/978-1-4615-6601-4_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Puddu, P., G. M. Puddu, C. Bozzoli, and A. Muscari. "Chronic ischemic heart disease: prevention and therapy." In Atherosclerosis and Cardiovascular Disease. Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-0731-7_72.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rostand, Stephen G., and Edwin A. Rutsky. "Ischemic Heart Disease in Chronic Renal Failure: Demography, Epidemiology, and Pathogenesis." In Cardiac Dysfunction in Chronic Uremia. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3902-5_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rysiak, Edyta, Izabela Prokop, Ilona Zaręba, and Robert M. Mróz. "Estimates of Medication Expenditure for Ischemic Heart Disease Accompanying Chronic Obstructive Pulmonary Disease." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/5584_2018_201.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kaplan, George A. "Psychosocial Aspects of Chronic Illness: Direct and Indirect Associations with Ischemic Heart Disease Mortality." In Behavioral Epidemiology and Disease Prevention. Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-7929-4_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Polat, Mehmet Oguz. "Systemic Diseases with Alcohol." In Medicolegal Aspect of Alcohol. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359487.6.

Full text

Abstract:

Alcohol consumption is a major risk factor for numerous systemic diseases, affecting various organs and systems in the body. The World Health Organization (WHO) identifies alcohol consumption as a high-risk factor for diseases such as ischemic heart disease and diabetes. The impact of alcohol is influenced by both the amount and patterns of drinking, with heavy and binge drinking contributing significantly to disease burden. Alcohol affects the immune system, increasing susceptibility to infectious diseases such as tuberculosis, HIV, and pneumonia. It is also classified as a carcinogen by the

APA, Harvard, Vancouver, ISO, and other styles

8

Demirtas, Bekir, and Ozgur Kazan. "Lhrh Agonist and Antagonist for Metastatic Prostate Cancer." In Current Management of Metastatic Prostate Cancer. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359142.2.

Full text

Abstract:

Alcohol consumption is a major risk factor for numerous systemic diseases, affecting various organs and systems in the body. The World Health Organization (WHO) identifies alcohol consumption as a high-risk factor for diseases such as ischemic heart disease and diabetes. The impact of alcohol is influenced by both the amount and patterns of drinking, with heavy and binge drinking contributing significantly to disease burden. Alcohol affects the immune system, increasing susceptibility to infectious diseases such as tuberculosis, HIV, and pneumonia. It is also classified as a carcinogen by the

APA, Harvard, Vancouver, ISO, and other styles

9

Havelková, Alena, Magda Krechlerová, Alena Pokorná, et al. "Muscle Preconditioning using electrostimulation of the lower limbs in hemodialysis patients." In Noninvasive Methods in Cardiology 2024. Masaryk University Press, 2024. https://doi.org/10.5817/cz.muni.m280-0669-2024-6.

Full text

Abstract:

The aim of the study was the use of modern electrotherapy of neuro-muscle-skeletal apparatus of both muscle quadriceps femoris and calf muscles (based in particular on the following types: a) transcutaneous electrical nerve stimulation, b) electrostimulation strength training; c) functional electrical stimulation; d) neuromuscular electrical stimulation (NMES) . Patients with ischemic heart disease were stimulated one hour three weeks. Three weeks of low frequency NMES applied to leg extensors increases significantly muscle power in HD patients and at least partly counterbalances the negative

APA, Harvard, Vancouver, ISO, and other styles

10

Moorthy, Aditya, and Shreya Krishna. "Management of Medical Comorbidities in Maxillofacial Surgery." In Oral and Maxillofacial Surgery for the Clinician. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-1346-6_3.

Full text

Abstract:

AbstractOral and Maxillofacial surgery, like any surgical specialty, has two vital requirements. First, having the right armamentarium, and, second, acquiring appropriate skills and knowledge of the patients’ disease process, including comorbidities. With the changing demographic in India, the profile of Indian patient has undergone a sea change in the last few decades. From acute conditions that had little impact on subsequent health of the patient, we have arrived at a scenario where a large proportion of patients present with chronic disorders like diabetes, ischemic heart diseases, etc. th

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Chronic ischemic heart disease"

1

Bhende, Kabo Clifford, Tshiamo Sigwele, Venumadhav Kuthadi, and Rajalakshmi Selvaraj. "Predicting Ischemic Heart Disease Using Supervised Learning Techniques on Clinical Data." In 2024 IEEE 4th International Conference on ICT in Business Industry & Government (ICTBIG). IEEE, 2024. https://doi.org/10.1109/ictbig64922.2024.10911500.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mishra, Ritunsa, Rabinarayan Satpathy, and Bibudhendu Pati. "Machine Learning Driven Remote Monitoring for Predictive Management of Chronic Heart Disease." In 2025 IEEE International Conference on Interdisciplinary Approaches in Technology and Management for Social Innovation (IATMSI). IEEE, 2025. https://doi.org/10.1109/iatmsi64286.2025.10984884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nahar, Sharmin, Zhonghui John Wang, Subhajit Chakrabarty, and Xi Jin. "Leveraging Selected Lifestyle Factors from NHANES Data for Chronic Heart Disease Risk Prediction." In 2025 Intermountain Engineering, Technology and Computing (IETC). IEEE, 2025. https://doi.org/10.1109/ietc64455.2025.11039383.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Jha, Sudhanshu, Dhandapani Vaithiyanathan, Preeti Verma, and Baljit Kaur. "An Automated Machine Learning Approach for Detecting Chronic Ischemic Heart Disease." In 2024 International Conference on Advances in Modern Age Technologies for Health and Engineering Science (AMATHE). IEEE, 2024. http://dx.doi.org/10.1109/amathe61652.2024.10582156.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Samaria, Jai K., Hemant Kumar, and Kapil Sharma. "Ischemic Heart Disease As A Co Morbidity In Patients With Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Didenko, Daria, Lesya Rasputina, Yuriy Mostovoy, and Nataliya Cherepii. "Features of clinical cours of chronic obstructive pulmonary disease and ischemic heart disease in case of comorbidity." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa641.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Didenko, Daria, Lesya Rasputina, Yuriy Mostovoy, and Nataliya Cherepii. "Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa3777.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jayamani, M., and R. K. Chopra. "Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in Stable Ischemic Heart Disease Patients Attending a Cardiac Clinic." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Vasiljevic, Zorana, Predrag Mitrovic, Dubravka Rajic, and Natasa Zlatic. "Coronary artery disease in patients with chronic kidney disease – is prevention possible?" In 7 th International Congress of Cardionephrology - KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.058v.

Full text

Abstract:

Coronary artery disease (CAD) and chronic kidney disease (CKD) may reciprocally influence each other and increased risk of many complications, especially ischemic and hemorrhagic events, which complicates the treatment and prognosis of these patients (pts). The pts with both diseases heart failure is present in 43% pts and acute myocardial (AMI) in 15% pts; the equivalent proportion in pts with CAD without kidney disease were 18.5% and 6.4% respectively (1). Not only the pts with CKD in advanced stage 4 or 5 are at high risk of CAD morbidity and mortality but, also the patients with early stag

APA, Harvard, Vancouver, ISO, and other styles

10

Киреева, Виктория, Viktoriya Kireeva, Ю. Усольцев, et al. "Intermediate results 2016 of a search study of translational diagnostic methods Mitochondrial dysfunction in patients with chronic myocardial ischemia and/or head Brain." In Topical issues of translational medicine: a collection of articles dedicated to the 5th anniversary of the day The creation of a department for biomedical research and technology of the Irkutsk Scientific Center Siberian Branch of RAS. INFRA-M Academic Publishing LLC., 2017. http://dx.doi.org/10.12737/conferencearticle_58be81ec94893.

Full text

Abstract:

Purpose of the study. To rate prognostic properties of changes in mitochondrial DNA concentration in the blood plasma of patients with chronic cerebral ischemia and ischemic heart disease in relation to the disease and the effectiveness of the therapy. Materials and methods. The study involved patients suffering from coronary heart disease (CHD) and chronic cerebral ischemia (CCI) with stable and unstable atherosclerotic plaques, who have signed informed consent to the data processing within the framework of scientific research. The patients were admitted to the hospital for examination and tr

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Chronic ischemic heart disease"

1

McCausland, Rachel, Joann Fontanarosa, and Ravi Patel. Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review. Agency for Healthcare Research and Quality (AHRQ), 2023. http://dx.doi.org/10.23970/ahrqepcrapidcoronary.

Full text

Abstract:

Aims. There is uncertainty around the optimal role of percutaneous coronary intervention (PCI) for management of chronic coronary syndrome, specifically when patients have disease in multiple coronary vessels and disease in the proximal portion of the left anterior descending coronary artery. This uncertainty was reflected in 2021 guidance from the American College of Cardiology (ACC)/American Heart Association (AHA) on coronary artery revascularization. The Agency for Healthcare Research and Quality has commissioned this rapid response literature review to meet a Congressional request for a s

APA, Harvard, Vancouver, ISO, and other styles

2

Wei, Dongmei, Yang Sun, and Hankang Hen. Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0080.

Full text

Abstract:

Review question / Objective: Can Baduanjin exercise improve the cardiac rehabilitation of patients with coronary artery disease after percutaneous coronary artery surgery? Condition being studied: Coronary heart disease (CHD), also known as coronary artery disease (CAD), is the single most common cause of death globally, with 7.4 million deaths in 2013, accounting for one-third of all deaths (WHO 2014). PCI has been shown to be effective in reducing mortality in patients with CHD. During follow-up, it has been shown that the benefits of PCI can be offset by the significant risks of coronary sp

APA, Harvard, Vancouver, ISO, and other styles

3

Pleszkoch, Mark G., Hilda B. Klasky, Aneel Advani, Edmon Begoli, Aileen Boone, and Stephan D. Fihn. Game Theoretic Approach for Understanding and Modeling Clinical Pathways (Stable Ischemic Heart Disease). Office of Scientific and Technical Information (OSTI), 2018. http://dx.doi.org/10.2172/1513403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Towne Jr, Samuel D., Timothy H. Callaghan, Alva O. Ferdinand, Marvellous Akinlotan, Kristin Primm, and Jane Bolin. Prevalence and Mortality of Heart Disease and Related Conditions: Disparities affecting the South, Rural Areas, and American India, and Alaska Natives. Southwest Rural Health Research Center, Texas A&M School of Public Health, 2019. http://dx.doi.org/10.21423/1969.1/201262.

Full text

Abstract:

Across the U.S., major health inequities persist across several social and structural determinants of health. In this brief, we explored the intersection of these social and structural determinants across major diseases and disease-related mortality. The likelihood of stroke, angina or coronary heart disease, and heart attack (myocardial infarction) was significantly higher in the South and for American Indian or Alaska Native individuals as compared to White individuals. Rural areas of the South experienced high rates of mortality for multiple years related to congestive heart failure, ischem

APA, Harvard, Vancouver, ISO, and other styles

5

Tan, Ling, Shan-shan Zhang, Lin-zi Long, et al. Growth factor for therapeutic angiogenesis in ischemic heart disease a meta-analysis of randomized controlled study. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Akzhigitova, D. Z., and S. S. Spitsina. Prevalence of rhythm disturbances and conduction of the heart in the structure of ischemic disease in rheumatoid arthritis. Actual problems of experimental and clinical medicine: Materials 77th International Scientific and Practical Conference of Young Scientists and students, 2019. http://dx.doi.org/10.18411/akzhigitova-d-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Doustmehraban, Maryam, Hengameh Ferdosian, Seyed Ali Emami, Elahe Sedighi, Mina Moridi, and Hadi Zamanian. Efficacy of online mindfulness in heart disease: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0055.

Full text

Abstract:

Review question / Objective: The aim of this systematic review is to investigate the efficacy of mindfulness interventions on physiologic and psychological outcomes in heart disease. Condition being studied: Heart disease is one of the most important life-threatening conditions and various psychological and physical treatments are considered for them. one of the psychological interventions which is used widely in a chronic disease context, is mindfulness-based interventions that could be delivered online. Information sources: Web OF Science Core Collection; EMBASE; Scopus; Psych Info.

APA, Harvard, Vancouver, ISO, and other styles

8

Lei, Yuping, Meili Wang, Guiqiang Sun, Yong Liu, Yapei Yang, and Dong Hao. Chinese herbal medicine injections (CHMIs) for chronic pulmonary heart disease: protocol for a Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Shalganov, Tchavdar, Milko Stoyanov, and Vassil Traykov. Outcomes following catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: protocol for an updated systematic review and meta-analysis of randomized studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.6.0080.

Full text

Abstract:

Review question / Objective: Does catheter ablation for scar-related monomorphic ventricular tachycardia improve outcomes (defined as any appropriate ICD therapy, appropriate ICD shocks, all-cause mortality, VT storm, cardiovascular mortality, cardiovascular hospitalizations, complications) in adult patients with ischemic or non-ischemic cardiomyopathy and implantable cardioverter-defibrillator? Condition being studied: Ventricular tachycardia in patients with structural heart disease is usually an arrhythmia using the myocardial scar as a substrate for reentry. It poses a risk of syncope and

APA, Harvard, Vancouver, ISO, and other styles

10

Lv, Wenming. Diagnostic performance of dynamic electrocardiography in the diagnosis of myocardial ischemic attack in coronary heart disease: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.6.0026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!